NE HEALTH BUREAU
HYDERABAD, OCT 24
Bharat Biotech has said that Covaxin, its ICMR-backed vaccine for Covid-19, is set for launch in June 2021.
The Hyderabad-based vaccine maker, which has received approval for phase 3 trials, will enroll 26,000 volunteers for the late-stage testing in November.
In our endeavour to bring out an effective solution to fight the COVID-19 pandemic, we are pleased to announce that Bharat Biotech has received DCGI approval to initiate Phase-3 clinical trials for COVAXIN™️.#BharatBiotech #COVAXIN #clinicaltrials #COVID19 #indiafightscorona pic.twitter.com/prVBnt30Av
— Bharat Biotech (@BharatBiotech) October 23, 2020
The trials will be conducted at around 30 sites in the country.
